SCHEMBL30202389

SCHEMBL30202389

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)CC)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 14/20 0.53
▸ MAGI3 Q5TCQ9 1/20 0.50
▸ GHSR Q92847 1/20 0.47
▸ EDNRA P25101 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ CASP4 P49662 1/20 0.46
▸ CASP5 P51878 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ CASP9 P55211 1/20 0.46
▸ CASP6 P55212 1/20 0.46
▸ CASP8 Q14790 1/20 0.46
▸ CASP10 Q92851 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29981789 0.86 IL23R (0.58) KISS1R
SCHEMBL29981546 0.85 MAGI3 (0.53) KISS1RMAGI3GHSREDNRACASP1
SCHEMBL30261890 0.85 MAGI3 (0.53) KISS1RMAGI3GHSREDNRACASP1
SCHEMBL29982709 0.85 MAGI3 (0.53) KISS1RMAGI3GHSREDNRACASP1
SCHEMBL30401759 0.83 KISS1R (0.61) KISS1R
SCHEMBL29982283 0.83 KISS1R (0.62) KISS1R
SCHEMBL30401709 0.83 KISS1R (0.62) KISS1R
SCHEMBL29981974 0.81 KISS1R (0.59) KISS1R
SCHEMBL29551233 0.80 GHSR (0.55) KISS1RGHSR
SCHEMBL31045811 0.79 MAGI3 (0.57) KISS1RMAGI3GHSREDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116920-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE PEPTIDREAM INC. (JP) 2026-04-30 — — US claimed
EP-4389758-A1 HUMAN TRANSFERRIN RECEPTOR?BINDING PEPTIDE PeptiDream Inc. (JP) 2024-06-26 — — EP claimed
WO-2023022234-A1 HUMAN TRANSFERRIN RECEPTOR–BINDING PEPTIDE ペプチドリーム株式会社 2023-02-23 — — WO claimed
US-20260116920-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE PEPTIDREAM INC. (JP) 2026-04-30 — — US disclosed
US-20260116920-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE PEPTIDREAM INC. (JP) 2026-04-30 — — US disclosed
EP-4389758-A1 HUMAN TRANSFERRIN RECEPTOR?BINDING PEPTIDE PeptiDream Inc. (JP) 2024-06-26 — — EP disclosed
EP-4389758-A1 HUMAN TRANSFERRIN RECEPTOR?BINDING PEPTIDE PeptiDream Inc. (JP) 2024-06-26 — — EP disclosed
WO-2023022234-A1 HUMAN TRANSFERRIN RECEPTOR–BINDING PEPTIDE ペプチドリーム株式会社 2023-02-23 — — WO disclosed
WO-2023022234-A1 HUMAN TRANSFERRIN RECEPTOR–BINDING PEPTIDE ペプチドリーム株式会社 2023-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116920-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE MET, TFRC, SLC7A1 KISS1R 2865/4885MAGI3 2671/4885GHSR 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback